Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Non-Current Deferred Tax Liability: 2010-2025

Historic Non-Current Deferred Tax Liability for China Pharma Holdings (CPHI) over the last 15 years, with Sep 2025 value amounting to $739,733.

  • China Pharma Holdings' Non-Current Deferred Tax Liability fell 1.38% to $739,733 in Q3 2025 from the same period last year, while for Sep 2025 it was $739,733, marking a year-over-year decrease of 1.38%. This contributed to the annual value of $731,202 for FY2024, which is 1.47% down from last year.
  • Latest data reveals that China Pharma Holdings reported Non-Current Deferred Tax Liability of $739,733 as of Q3 2025, which was up 0.75% from $734,246 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Non-Current Deferred Tax Liability registered a high of $827,978 during Q1 2022, and its lowest value of $727,417 during Q2 2023.
  • Its 3-year average for Non-Current Deferred Tax Liability is $739,306, with a median of $737,522 in 2024.
  • Per our database at Business Quant, China Pharma Holdings' Non-Current Deferred Tax Liability increased by 9.59% in 2021 and then declined by 8.65% in 2022.
  • Over the past 5 years, China Pharma Holdings' Non-Current Deferred Tax Liability (Quarterly) stood at $824,407 in 2021, then dropped by 8.46% to $754,698 in 2022, then declined by 1.67% to $742,114 in 2023, then fell by 1.47% to $731,202 in 2024, then decreased by 1.38% to $739,733 in 2025.
  • Its Non-Current Deferred Tax Liability was $739,733 in Q3 2025, compared to $734,246 in Q2 2025 and $732,241 in Q1 2025.